Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A.   Nielsen D.   Engelholm S.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Serum CA-125 Screening for Ovarian Cancer in Patients with Dermatomyositis

By Whitmore S.E.   Anhalt G.J.   Provost T.T.   Zacur H.A.   Hamper U.M.   Helzlsouer K.J.   Rosenshein N.B.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite

The Relationship between Postoperative Decline of Serum CA 125 Levels and Size of Residual Disease after Initial Surgery in Patients with Advanced Ovarian Cancer: A CTF Study

By Gadducci A.   Landoni F.   Maggino T.   Sartori E.   Zola P.   Fanucchi A.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 234-237

Academic Press

Access to resources Recommend Favorite

Predictive and Prognostic Values of Cancer-Associated Serum Antigen (CASA) and Cancer Antigen 125 (CA 125) Levels Prior to Second-Look Laparotomy for Ovarian Cancer

By Kierkegaard O.   Mogensen O.   Mogensen B.   Jakobsen A.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 251-254

Academic Press

Access to resources Recommend Favorite

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

By Topalak O.   Saygili U.   Soyturk M.   Karaca N.   Batur Y.   Uslu T.   Erten O.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 108-113

Elsevier

Access to resources Recommend Favorite